Treatment-Resistant Heart Failure (HF) and Peritoneal Ultrafiltration (PUF): A Randomized Prospective Trial of Standard Care Versus Standard Care With Peritoneal Ultrafiltration in Patients With Treatment-Resistant Severe Heart Failure
Overview
- Phase
- Phase 2
- Intervention
- Extraneal
- Conditions
- Congestive Heart Failure
- Sponsor
- Vantive Health LLC
- Enrollment
- 12
- Primary Endpoint
- All-cause Hospitalization (Unadjusted)
- Status
- Terminated
- Last Updated
- 9 months ago
Overview
Brief Summary
The objective of the study is to determine if the addition of peritoneal ultrafiltration to standard therapy in treatment-resistant severe heart failure patients will improve fluid balance and functional capacity such that they will spend less time in the hospital and have an improved ambulatory quality of life in comparison to patients who remain on standard therapy alone.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adults with congestive heart failure (CHF) who remain fluid overloaded despite standard treatment.
Exclusion Criteria
- •Patients who have reversible CHF or have diseases or conditions that would contraindicate the use of peritoneal dialysis.
Arms & Interventions
Intervention
peritoneal dialysis
Intervention: Extraneal
Outcomes
Primary Outcomes
All-cause Hospitalization (Unadjusted)
Time Frame: 6 to 24 months
All-cause hospitalization was defined as (1) hospitalization for any cause of any duration or (2)any ER visit or any clinic visit specifically for congestive heart failure requiring intravenous administration of an inotrope, vasodilator or diuretic.